Status: Available
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
This is a compassionate use protocol to allow patients with advanced neuroblastoma palliative access to 131I-metaiodobenzylguanidine (131I-MIBG).
Trial details
Age: 1+Biological sex: AllType: Expanded AccessSponsor: Kieuhoa VoUpdated: Jul 23, 2026Locations: 1
Eligibility criteria
Diagnosis: Refractory or relapsed neuroblastoma with original diagnosis based on... [+14]
Patients with disease of any major organ system that would compromise their abil... [+4]